Merck's Q4 Earnings in Focus: Can the Pharma Giant Sustain Its Momentum?
As Merck prepares to release its fourth-quarter results, investors are watching to see if the pharmaceutical leader can maintain its track record of exceeding expectations amid a slowing growth outlook.